| (V1143) |
Time for larger Devices for Transcatheter Aortic Valve Implantation |
|
D. John, S. Hausen, G. Latsios, S. Yücel, H.-C. Eberle, M. Farazandeh, R. Müller, C. K. Naber, T. Schlosser, L. Büllesfeld, U. Gerckens, O. Bruder, E. Grube (Essen, Siegburg; Bern, CH) |
| (V1144) |
Transarterial Aortic Valve Replacement Using the Medtronic CoreValve System: Access Site Complications and Impact of Vascular Mortality on 30day Mortality |
|
F. Woitek, M. Uhlemann, M. Woinke, S. Möbius-Winkler, J. Ender, T. Walther, F. W. Mohr, G. C. Schuler, A. Linke (Leipzig) |
| (V1145) |
Need for Pacemaker Implantation after Percutaneous Treatment of Aortic Valve Stenosis using the Medtronic CoreValve ReValving System |
|
F. Woitek, A. Linke, M. Uhlemann, S. Möbius-Winkler, M. Woinke, T. Walther, F. W. Mohr, G. C. Schuler (Leipzig) |
| (V1146) |
Cerebral Embolization during Transcatheter Aortic Valve Implantation (TAVI): A Transcranial Doppler Study. |
|
P. Kahlert, P. Doettger, K. Mori, F. Al-Rashid, M. Thielmann, D. Wendt, M. Schlamann, H. G. Jakob, R. Erbel, H. Eggebrecht (Essen) |
| (V1147) |
First-in-Man Experience with a novel cerebral protection device for percutaneous aortic valve implantation. |
|
J. Schofer, K. Bijuklic, J. G. Webb, U. Gerckens, R. Müller (Hamburg, Siegburg; Vancouver, CA) |
| (V1148) |
The Value of Doppler-based Renal Arterial Resisitive Index to predict Acute Kidney Injury after Transcatheter Aortic Valve Implantation |
|
J.-M. Sinning, V. Adenauer, A. Ghanem, C. Hammerstingl, G. Nickenig, N. Werner (Bonn) |